Martha E. Linsenmeyer

Reversal of the multidrug resistance phenotype with cremophor EL, a common vehicle for water-insoluble vitamins and drugs.

D.M. Woodcock, Sara Jefferson, Martha E. Linsenmeyer et al. · PubMed · 1990 · 168 citations

Medicine, Pharmacology, Pharmacotherapy +12

Asymmetric Methylation in the Hypermethylated CpG Promoter Region of the Human L1 Retrotransposon

D.M. Woodcock, Celine B. Lawler, Martha E. Linsenmeyer et al. · Journal of Biological Chemistry · 1997 · 167 citations · Full text

Medicine, Genetics, Molecular Biology +13

Measurement of Cremophor EL Following Taxol: Plasma Levels Sufficient to Reverse Drug Exclusion Mediated by the Multidrug-Resistant Phenotype

Lorraine K. Webster, Martha E. Linsenmeyer, Michael Millward et al. · JNCI Journal of the National Cancer Institute · 1993 · 129 citations · Full text

Medicine, Oncology, Pharmacology +17

DNA methylation in the promoter region of the p16 (CDKN2/MTS-1/INK4A) gene in human breast tumours

D.M. Woodcock, Martha E. Linsenmeyer, J.P. Doherty et al. · British Journal of Cancer · 1998 · 41 citations · Full text

Medicine, Molecular Biology, Oncology +17

Revised genomic consensus for the hypermethylated CpG island region of the human L1 transposon and integration sites of full length L1 elements from recombinant clones made using methylation-tolerant host strains

P.J. Crowther, J.P. Doherty, Martha E. Linsenmeyer et al. · Nucleic Acids Research · 1991 · 38 citations · Full text

Life Sciences, Genetics, Molecular Genetics +15